pageInfo({
    time : "1260983728348"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "UST18505320080303"
	        , headline : "UPDATE 1-Eisai nausea drug gets U.S. additional use approval"
	        , keywords : "[Regulation and enforcement, Pharmaceuticals - generic and speciality, Pharmaceuticals (sub-industry), Japan, Asia, France, Western Europe, Europe, Pharmaceuticals - diversified, United Kingdom, Switzerland, Healthcare, Pharmaceuticals and biotechnology, Health and medicine, Central and Eastern Europe, Economic news, EC, business/financial pages]"
	        , tickers : "[us;SNYN, mx;GSKN, ROG.VX, SASY.PA, us;ESAL, us;GLAX, us;GSK, us;RHHB, us;RHHD, us;RHHG, us;RHHQ, us;RHHV, us;SNY, jp;N225, jp;4523, ch;RO, de;EII, de;EIIF, de;EIIS, de;EIIX, de;GS7, fr;SAN, gb;AP47, gb;GSK, gb;SNF, GSK.L, it;SANF, 4523.T]"
	    }
	    , channel : {
	        id : "108"
	        , name : "governmentFilingsNews"
	        , title : "Regulatory News"
	    }})